S2-E23.1 - From the Fourth Global NASH Congress -- Diagnosing Diagnostics

S2-E23.1 – From the Fourth Global NASH Congress — Diagnosing Diagnostics

The SurfingNASH Team has curated over three hours of recordings from the Fourth Global NASH Congress to highlight pieces that discuss the current and future states of diagnostics in Fatty Liver disease. You will hear Manal Abdelmalek, Naim Alkhouri, Suneil Hosmane, Ian Rowe, Jörn Schattenberg, Louise Campbell and Roger Green sharing opinions and debating issues.

Discussions about diagnostics ran through SurfingNASH’s entire coverage of the Fourth Global NASH Congress. Listen here for some of the diagnostics highlights. The group discusses exciting new precision diagnostics, urine and breath-based biopsies, realistic expectations for diagnostics in market today and implications for clinical trials and patient treatment and other related questions in a fast-moving set of pieces.

TOPICS: AASLD, cirrhosis, Diagnostic Tests, DrugTrial, EchoSens, Elastography, ELF, Fatty Liver, FIB-4, FibroScan, Fibrosis Level 3, Fibrosis Level 4, Genfit, Gilead Sciences, MRI-PDFF, NAFLD, NASH, non-invasive liver testing, Nordic Biosciences, Phase3, Siemens Healthineers, Tawazun Health, TrialDesign,

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast

Request A Transcript of This Episode
Request Transcript
First
Last

Join The Discussion…

Ask Our Panelists A Question…

Podcast Quesitonaire
Is your question directed towards one of our panelists?

If your question is answered in our next Podcast, would you like be tagged?

Join The Discussion!

Subscribe to our free emails. Receive access to our Discussion Group. Ask your questions directly to our "Surfers"